Ventyx Biosciences IncNASDAQ:VTYX
- LAST PRICE4.1700
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots4.0500/ 2
- Ask / Lots4.1700/ 2
- Open / Previous Close0.0000 / 4.1700
- Day Range---
- 52 Week Range
- Volume82
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | VTYX |
|---|---|---|
| 09:32 ET | 7818 | 4.21 |
| 09:34 ET | 6100 | 4.274 |
| 09:36 ET | 300 | 4.23 |
| 09:38 ET | 8818 | 4.23 |
| 09:39 ET | 1100 | 4.28 |
| 09:41 ET | 2730 | 4.31 |
| 09:43 ET | 2215 | 4.31 |
| 09:45 ET | 1141 | 4.33 |
| 09:48 ET | 1790 | 4.33 |
| 09:50 ET | 14059 | 4.4 |
| 09:52 ET | 907 | 4.4 |
| 09:54 ET | 14462 | 4.41 |
| 09:56 ET | 200 | 4.41 |
| 09:57 ET | 1678 | 4.405 |
| 09:59 ET | 2012 | 4.4 |
| 10:01 ET | 2508 | 4.4014 |
| 10:03 ET | 300 | 4.41 |
| 10:06 ET | 1100 | 4.425 |
| 10:08 ET | 3344 | 4.41 |
| 10:10 ET | 1610 | 4.36 |
| 10:12 ET | 12913 | 4.39 |
| 10:14 ET | 3064 | 4.395 |
| 10:15 ET | 2825 | 4.38 |
| 10:17 ET | 500 | 4.37 |
| 10:19 ET | 644 | 4.3584 |
| 10:21 ET | 2466 | 4.35 |
| 10:24 ET | 2353 | 4.3634 |
| 10:26 ET | 102 | 4.3663 |
| 10:28 ET | 3770 | 4.34 |
| 10:30 ET | 2625 | 4.35 |
| 10:32 ET | 1784 | 4.374 |
| 10:33 ET | 506 | 4.38 |
| 10:35 ET | 12759 | 4.32 |
| 10:37 ET | 429 | 4.305 |
| 10:39 ET | 3079 | 4.24 |
| 10:42 ET | 666 | 4.2573 |
| 10:44 ET | 5090 | 4.25 |
| 10:46 ET | 7700 | 4.26 |
| 10:48 ET | 300 | 4.26 |
| 10:50 ET | 600 | 4.3 |
| 10:51 ET | 1100 | 4.33 |
| 10:53 ET | 1300 | 4.35 |
| 10:55 ET | 2922 | 4.35 |
| 10:57 ET | 200 | 4.35 |
| 11:00 ET | 590 | 4.36 |
| 11:02 ET | 1782 | 4.35 |
| 11:04 ET | 100 | 4.36 |
| 11:06 ET | 800 | 4.36 |
| 11:08 ET | 2549 | 4.36 |
| 11:09 ET | 1300 | 4.37 |
| 11:11 ET | 3703 | 4.37 |
| 11:13 ET | 2215 | 4.35 |
| 11:20 ET | 3275 | 4.33 |
| 11:22 ET | 400 | 4.32 |
| 11:24 ET | 1300 | 4.33 |
| 11:27 ET | 12037 | 4.345 |
| 11:29 ET | 1000 | 4.3603 |
| 11:31 ET | 500 | 4.37 |
| 11:36 ET | 627 | 4.37 |
| 11:38 ET | 1876 | 4.36 |
| 11:44 ET | 1600 | 4.325 |
| 11:49 ET | 1300 | 4.34 |
| 11:51 ET | 482 | 4.33 |
| 11:54 ET | 100 | 4.33 |
| 11:56 ET | 7046 | 4.36 |
| 11:58 ET | 100 | 4.37 |
| 12:00 ET | 592 | 4.35 |
| 12:02 ET | 947 | 4.36 |
| 12:03 ET | 900 | 4.36 |
| 12:05 ET | 128 | 4.36 |
| 12:07 ET | 1000 | 4.35 |
| 12:09 ET | 300 | 4.34 |
| 12:12 ET | 200 | 4.33 |
| 12:16 ET | 711 | 4.325 |
| 12:18 ET | 1968 | 4.33 |
| 12:20 ET | 540 | 4.33 |
| 12:21 ET | 2107 | 4.36 |
| 12:23 ET | 6121 | 4.35 |
| 12:25 ET | 5700 | 4.33 |
| 12:27 ET | 400 | 4.33 |
| 12:30 ET | 500 | 4.3225 |
| 12:32 ET | 3089 | 4.34 |
| 12:34 ET | 401 | 4.35 |
| 12:36 ET | 300 | 4.34 |
| 12:38 ET | 100 | 4.35 |
| 12:39 ET | 400 | 4.34 |
| 12:41 ET | 529 | 4.35 |
| 12:43 ET | 445 | 4.335 |
| 12:45 ET | 700 | 4.3375 |
| 12:48 ET | 2320 | 4.35 |
| 12:50 ET | 300 | 4.36 |
| 12:52 ET | 2973 | 4.37 |
| 12:54 ET | 2286 | 4.355 |
| 12:56 ET | 2950 | 4.35 |
| 12:57 ET | 240 | 4.35 |
| 01:01 ET | 200 | 4.35 |
| 01:03 ET | 100 | 4.35 |
| 01:06 ET | 1673 | 4.34 |
| 01:08 ET | 576 | 4.34 |
| 01:12 ET | 549 | 4.345 |
| 01:17 ET | 4200 | 4.335 |
| 01:19 ET | 2300 | 4.35 |
| 01:21 ET | 100 | 4.345 |
| 01:24 ET | 2199 | 4.335 |
| 01:26 ET | 100 | 4.33 |
| 01:30 ET | 6772 | 4.33 |
| 01:32 ET | 16726 | 4.325 |
| 01:33 ET | 100 | 4.325 |
| 01:35 ET | 12191 | 4.27 |
| 01:37 ET | 541 | 4.28 |
| 01:39 ET | 200 | 4.27 |
| 01:42 ET | 100 | 4.27 |
| 01:44 ET | 100 | 4.27 |
| 01:46 ET | 753 | 4.28 |
| 01:48 ET | 1596 | 4.265 |
| 01:50 ET | 100 | 4.27 |
| 01:51 ET | 4966 | 4.2485 |
| 01:53 ET | 3284 | 4.22 |
| 01:57 ET | 200 | 4.22 |
| 02:00 ET | 4960 | 4.235 |
| 02:02 ET | 200 | 4.235 |
| 02:04 ET | 300 | 4.235 |
| 02:06 ET | 100 | 4.24 |
| 02:08 ET | 6010 | 4.25 |
| 02:09 ET | 1200 | 4.26 |
| 02:11 ET | 800 | 4.26 |
| 02:13 ET | 400 | 4.26 |
| 02:15 ET | 1692 | 4.26 |
| 02:18 ET | 571 | 4.265 |
| 02:20 ET | 5326 | 4.251 |
| 02:22 ET | 1939 | 4.24 |
| 02:24 ET | 1231 | 4.22 |
| 02:26 ET | 2200 | 4.215 |
| 02:27 ET | 300 | 4.215 |
| 02:29 ET | 100 | 4.215 |
| 02:31 ET | 5336 | 4.21 |
| 02:33 ET | 7300 | 4.2 |
| 02:36 ET | 100 | 4.19 |
| 02:38 ET | 200 | 4.2 |
| 02:42 ET | 736 | 4.192 |
| 02:45 ET | 6067 | 4.22 |
| 02:47 ET | 9321 | 4.21 |
| 02:49 ET | 400 | 4.21 |
| 02:51 ET | 4824 | 4.2 |
| 02:56 ET | 300 | 4.2 |
| 03:00 ET | 3360 | 4.2 |
| 03:02 ET | 100 | 4.19 |
| 03:05 ET | 400 | 4.19 |
| 03:09 ET | 2500 | 4.195 |
| 03:12 ET | 200 | 4.195 |
| 03:14 ET | 400 | 4.195 |
| 03:16 ET | 200 | 4.195 |
| 03:18 ET | 14562 | 4.16 |
| 03:21 ET | 100 | 4.16 |
| 03:23 ET | 4499 | 4.185 |
| 03:25 ET | 500 | 4.185 |
| 03:27 ET | 600 | 4.19 |
| 03:30 ET | 2750 | 4.185 |
| 03:32 ET | 771 | 4.185 |
| 03:34 ET | 600 | 4.18 |
| 03:36 ET | 20529 | 4.17 |
| 03:39 ET | 416 | 4.17 |
| 03:41 ET | 602 | 4.175 |
| 03:43 ET | 4988 | 4.175 |
| 03:45 ET | 9548 | 4.185 |
| 03:48 ET | 9959 | 4.16 |
| 03:50 ET | 239 | 4.1699 |
| 03:52 ET | 4791 | 4.175 |
| 03:54 ET | 5166 | 4.18 |
| 03:56 ET | 11504 | 4.17 |
| 03:57 ET | 1800 | 4.17 |
| 03:59 ET | 17214 | 4.17 |
Yesterday
NASDAQ INVESTIGATION NOTIFICATION Leading Law Firm BFA LLP Alerts VTYX Investors that Directors of Ventyx Biosciences Are Being Investigated for Potential Breaches of Fiduciary Duty, from 15 hours ago by Dow Jones
15 hours ago by Dow JonesVENTYX BIOSCIENCES, INC. (NASDAQ: VTYX) SHAREHOLDER ALERT: The Directors of Ventyx Biosciences, Inc. Are Being Investigated for Potential Breaches of Fiduciary Duty by Leading Law Firm Bleichmar Fonti & Auld LLP; Contact the Firm for More Details, from 23 hours ago by Dow Jones
23 hours ago by Dow Jones
May 13, 2024
VTYX ALERT: Top Law Firm Bleichmar Fonti & Auld LLP Is Investigating the Directors of Ventyx Biosciences, Inc. for Potential Breaches of Fiduciary Duty; Contact the Firm for More Details, from 9:03PM ET on Monday May 13, 2024 by Dow Jones
9:03PM ET on Monday May 13, 2024 by Dow JonesVENTYX BIOSCIENCES, INC. INVESTIGATION ALERT (NASDAQ:VTYX): Top Law Firm Bleichmar Fonti & Auld LLP Notifies Investors that the Directors of Ventyx Biosciences, Inc. Are Being Investigated for Potential Breaches of Fiduciary Duty; Investors Are Encouraged to Contact the Firm, from 5:03AM ET on Monday May 13, 2024 by Dow Jones
5:03AM ET on Monday May 13, 2024 by Dow Jones
May 11, 2024
VENTYX BIOSCIENCES, INC. INVESTOR ALERT (NASDAQ: VTYX): The Directors of Ventyx Biosciences, Inc. Are Being Investigated for Potential Breaches of Fiduciary Duty; Top Law Firm Bleichmar Fonti & Auld LLP Encourages Investors to Contact the Firm, from 4:17AM ET on Saturday May 11, 2024 by Dow Jones
4:17AM ET on Saturday May 11, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Ventyx Biosciences Inc | 294.0M | -1.3x | --- |
Actinium Pharmaceuticals Inc | 294.6M | -5.7x | --- |
Rani Therapeutics Holdings Inc | 291.4M | -4.5x | --- |
Invivyd Inc | 289.7M | -1.3x | --- |
Inozyme Pharma Inc | 286.0M | -3.4x | --- |
Inovio Pharmaceuticals Inc | 289.3M | -2.1x | --- |
Company Information
Ventyx Biosciences, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing a pipeline of small molecule product candidates to address a range of inflammatory diseases with unmet need. The Company’s pipeline includes VTX002 (S1P1R Modulator), VTX958 (TYK2 Inhibitor), and VTX2735 and VTX3232 (NLRP3 Inhibitor Portfolio). VTX002 is a sphingosine 1 phosphate receptor (S1P1R) modulator in Phase II development for patients with moderately to severely active ulcerative colitis (UC). VTX958 is an oral, selective clinical-stage inhibitor of tyrosine kinase type 2 (TYK2), an intracellular signaling kinase in the Janus kinase (JAK) family that regulates chronic inflammation in immune-mediated diseases. Its third product candidate, VTX2735, is a peripheral-targeted NOD-like receptor protein 3 (NLRP3) inflammasome inhibitor. In addition to VTX2735, it is also developing VTX3232, its lead CNS-penetrant NLRP3 inhibitor in Phase 1 development.
Contact Information
- Headquarters
- 12790 El Camino Real, Suite 200SAN DIEGO, CA, United States 92130
- Phone
- 858-945-2393
- Fax
- 302-655-5049
Executives
- Executive Chairperson of the Board
- Sheila Gujrathi
- President, Chief Executive Officer, Founder, Director
- Raju Mohan
- Chief Financial Officer
- Martin Auster
- Chief Scientific Officer
- John Nuss
- Independent Director
- Onaiza Cadoret-manier
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $294.0M |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 70.5M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | --- |
EPS | $-3.24 |
Book Value | $4.12 |
P/E Ratio | -1.3x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
